Gold’s status as a portfolio diversifier has come into sharper focus this week as the precious metal broke through the landmark $4,000 level. The commodity — long established as a safe-haven asset in times of turmoil — has rallied this year…
Category: 6. Business
-
Integrating pollution registers for corporate climate-risk assessment
The year 2024 was confirmed by the Copernicus Climate Change Service to be the warmest year on record globally, and the first calendar year that the average global temperature exceeded 1.5°C above its…
Continue Reading
-
How firms respond to import competition: Labour force reduction, product/industry switching, and off-shoring
As global trade has expanded – especially with the ascent of China – concerns about job losses and deindustrialisation in high-income countries have grown. While many studies document the level of impact of…
Continue Reading
-
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
- EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO),…
Continue Reading
-
Zero emission zones: The Netherlands’ path to cleaner urban freight – International Council on Clean Transportation
- Zero emission zones: The Netherlands’ path to cleaner urban freight International Council on Clean Transportation
- Dutch model drives Europe’s zero-emission freight shift Cities Today
- Dutch zero-emission zones drive huge increase in fleet…
Continue Reading
-
Adam S. Posen on why inflation impact from tariffs and deportations has been lagged – Peterson Institute for International Economics
- Adam S. Posen on why inflation impact from tariffs and deportations has been lagged Peterson Institute for International Economics
- Who’s Going to ‘Eat’ Tariffs? Not US Shoppers Bloomberg.com
- Impact of Trump tariffs is beginning to show in…
Continue Reading
-
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome – Biogen
- Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome Biogen
- Beyond Seizures: Zorevunersen’s Impact…
Continue Reading
-
Johnson & Johnson to Participate in the UBS Global Healthcare Conference
New Brunswick, N.J., October 9th, 2025 – Johnson & Johnson (NYSE: JNJ) will present at the UBS Global Healthcare Conference on Tuesday, November 11th, 2025. Management will participate in a Fireside Chat at…
Continue Reading
-
UiPath Recognized as a Leader in the Gartner® Magic Quadrant™ for AI-Augmented Software Testing Tools :: UiPath, Inc. (PATH)
UiPath Test Cloud helps enterprises validate speed, identify bottlenecks and eliminate repetitive workflows to drive greater productivity
NEW YORK–(BUSINESS WIRE)–
UiPath (NYSE: PATH), a…Continue Reading
